AlphaMeld Corporation
Madan Anant is an accomplished professional in the fields of drug discovery and biomarker research, currently serving as Vice President of Discovery Biology and Executive Director of Drug Discovery at InveniAI since October 2021. Anant has held various senior roles, including Senior Director of Alliances at InveniAI Corporation and Scientific & Business Development Consultant at Recombinant Technologies. With a robust consulting background for several biotechnology firms, Anant has successfully led projects involving novel biomarker detection platforms, performed scientific due diligence, and managed collaborations across multiple therapeutic areas. Anant's extensive experience spans over two decades, featuring previous positions at Clinical Data, Inc., Genaissance Pharmaceuticals, Gene Logic, and CuraGen Corporation. Anant earned a Ph.D. in Life Sciences from the Indian Institute of Science, further establishing a strong foundation for expertise in scientific and business development within the life sciences sector.
This person is not in any offices